Catastrophic thinking about pain increases discomfort during internal atrial cardioversion

Journal of Psychosomatic Research

Volumn 56, Issue 1, 2004, Pages 139-144

  Vlaeyen, Johan W S ^a,b   Timmermans, Carl ^b   Rodriguez, Luz Maria ^b   Crombez, Geert ^c   Van Horne, Wendy ^b   Ayers, Gregory M ^b   Albert, Adelin ^d   Wellens, Hein J J ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Atrium; Cardioversion; Catastrophizing; Discomfort; Fibrillation

Indexed keywords

ANALGESIC AGENT; BUTORPHANOL TARTRATE; PLACEBO;

ADULT; ANXIETY; ARTICLE; BEHAVIOR THERAPY; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EVALUATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERALGESIA; INTERMETHOD COMPARISON; MALE; MOOD; PAIN ASSESSMENT; PREDICTION; RATING SCALE; SOCIAL DISABILITY;

EID: 1342329247     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(03)00081-3     Document Type: Article

References (16)

1. Timmermans C., Rodriguez L.M., Ayers G.M., Lambert H., Smeets J.L., Vlaeyen J.W., Albert A., Wellens H.J. Effect of butorphanol tartrate on shock-related discomfort during internal atrial defibrillation. Circulation. 99(14):1999;1837-1842.
2. Murgatroyd F.D., Slade A.K.B., Sopher S.M., Rowland E., Ward D.E., Camm A.J. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol. 25:1995;1347-1353.
3. Sullivan M.J.L., Bishop S.R., Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assess. 7:1995;524-532.
4. Crombez G, Vlaeyen JWS. The Pain Catastrophizing Scale: unpublished authorized Dutch/Flemish translation, 1996.
5. Crombez G., Eccleston C., Baeyens F., Eelen P. When somatic information threatens, catastrophic thinking enhances attentional interference. Pain. 75(2-3):1998;187-198.
6. Pauli P., Wiedemann G., Dengler W., Blaumann-Benninghoff G., Kuhlkamp V. Anxiety in patients with an automatic implantable cardioverter defibrillator: what differentiates them from panic patients? Psychosom Med. 61(1):1999;69-76.
7. Van Damme S., Crombez G., Bijttebier P., Goubert L., Van Houdenhove B. A confirmatory factor analysis of the Pain Catastrophizing Scale: invariant factor structure across clinical and non-clinical populations. Pain. 96(3):2002;319-324.
8. Denollet J. Health complaints and outcome assessment in coronary heart disease. Psychosom Med. 56(5):1994;463-474.
9. Denollet J. Emotional distress and fatigue in coronary heart disease: the Global Mood Scale (GMS). Psychol Med. 23(1):1993;111-121.
10. Erdman R.A.M. Medische Psychologische Vragenlijst voor Hartpatiënten. Heart Patients Psychological Questionnaire:1982;Swets & Zeitlinger, Lisse.
11. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1(3):1975;277-299.
12. Verkes R.J., Vanderiet K., Vertommen H., van der Kloot W.A., van der Meij J. De MPQ-DLV, een standaard Nederlandstalige versie van de McGill Pain Questionnaire voor Belgie en Nederland. van der Kloot W.A., Vertommen H. De MPQ-DLV, een standaard Nederlandstalige versie van de McGill Pain Questionnaire: achtergronden en handleiding. 1989;57-69 Swets & Zeitlinger, Lisse.
13. Eysenck M.W. Anxiety and cognition. A unified theory. 1997;Psychology Press, Hove.
14. Godemann F., Ahrens B., Behrens S., Berthold R., Gandor C., Lampe F., Linden M. Classic conditioning and dysfunctional cognitions in patients with panic disorder and agoraphobia treated with an implantable cardioverter/ defibrillator. Psychosom Med. 63(2):2001;231-238.
15. Ehlers A., Breuer P. How good are patients with panic disorder at perceiving their heartbeats? Biol Psychol. 42(1-2):1996;165-182.
16. Arntz A., Dreessen L., Merckelbach H. Attention, not anxiety, influences pain. Behav Res Ther. 29(1):1991;41-50.